Journal of Capital Medical University ›› 2008, Vol. 29 ›› Issue (1): 12-14.

• 专题报道 • Previous Articles     Next Articles

The Use of PET Imaging in the Evaluation of Alzheimer's Disease Rat Model

Guo Zhe1, Wang Ruimin1, Zhang Jinming1, Li Xuling2, Yao Shulin1, Tian Jiahe1   

  1. 1. Department of Nuclear Medicine, General Hospital of PLA;2. Department of Neurology, the First Affiliated Hospital of Harbin Medical University
  • Received:2007-11-18 Revised:1900-01-01 Online:2008-02-24 Published:2013-07-15

Abstract: Objective To investigate the value of 18F-FDG and 4'-schiff-O[11CH3]PET imaging in the evaluation of Alzheimer's disease rat model.Methods Ten AD rat models and 10 control rats had undergone the 18F-FDG and 4'-schiff-O[11CH3]PET studies.The sections of the brain tissues of both control and AD model rats were stained with HE and Congo red.Results PET imaging of AD rats showed reduced glucose metabolism and high uptake of 4'-schiff-O[11CH3] in the injected side.Diffuse neuronal loss and Aβdeposition were detected in the hippocampi and cortices in the AD rats;in contrast,such changes were almost not seen in control rats.Conclusion 18F-FDG and 4'-schiff-O[11CH3] PET imaging,combining with the behavioral and pathological observations can set up standards of verifying the AD rat model,and it provides a molecular imaging tool for the basic research and clinic diagnosis of AD.

Key words: Alzheimer's disease, AD rat models, 1~40, 4'-schiff-O[11CH3], 18F-FDG, PET

CLC Number: